Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.
作者信息
Baum M
出版信息
Br J Cancer. 1984 Feb;49(2):117-22. doi: 10.1038/bjc.1984.22.
Abstract
摘要
相似文献
1
Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.
Br J Cancer. 1984 Feb;49(2):117-22. doi: 10.1038/bjc.1984.22.
2
Adjuvant chemoendocrine therapy in breast cancer.
J Clin Oncol. 1986 Apr;4(4):451-4. doi: 10.1200/JCO.1986.4.4.451.
3
Management of breast cancer with hormones and drugs.
Hosp Pract (Off Ed). 1986 May 15;21(5):119-27, 131.
4
Current controversies in breast cancer management.
Curr Probl Surg. 1999 Mar;36(3):163-216.
5
Adjuvant systemic therapy in primary breast cancer.
Acta Chir Scand Suppl. 1984;519:43-53.
6
The nature of tamoxifen action in the control of female breast cancer.
In Vivo. 2001 Jul-Aug;15(4):319-25.
7
8
Breast cancer in the elderly.
Bull N Y Acad Med. 1992 Nov;68(4):476-82.
9
Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.
World J Surg. 1985 Oct;9(5):756-64. doi: 10.1007/BF01655191.
10
[Hormone therapy of patients with breast cancer].
Vopr Onkol. 1984;30(11):3-9.
引用本文的文献
1
Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.
World J Surg. 1985 Oct;9(5):756-64. doi: 10.1007/BF01655191.
2
Skeletal effects of carcinoma of the breast and prostate.
Ann R Coll Surg Engl. 1986 Sep;68(5):267-70.
3
Progress in understanding breast cancer: epidemiological and biological interactions.
Breast Cancer Res Treat. 1988 May;11(2):91-112. doi: 10.1007/BF01805834.
本文引用的文献
1
THE SIGNIFICANCE OF REGIONAL LUMPH NODE METASTASES IN BREAST CARCINOMA.
Can Med Assoc J. 1965 Aug 14;93(7):289-93.
2
Dose-response effect of adjuvant chemotherapy in breast cancer.
N Engl J Med. 1981 Jan 1;304(1):10-5. doi: 10.1056/NEJM198101013040103.
3
Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor.
Nature. 1980 Dec 11;288(5791):600-2. doi: 10.1038/288600a0.
4
The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.
Cancer. 1980 Aug 15;46(4 Suppl):1009-25. doi: 10.1002/1097-0142(19800815)46:4+<1009::aid-cncr2820461326>3.0.co;2-h.
5
An antiestrogen-binding protein in human tissues.
J Biol Chem. 1983 Mar 10;258(5):3173-7.
6
Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins.
Adv Prostaglandin Thromboxane Leukot Res. 1983;12:299-302.
7
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer.
Lancet. 1983 Aug 20;2(8347):450. doi: 10.1016/s0140-6736(83)90406-3.
8
Macrophage production by the bone marrow of tumor-bearing mice.
Cancer Res. 1972 Dec;32(12):2813-7.
9
Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.
Cancer. 1977 Nov;40(5):2290-8. doi: 10.1002/1097-0142(197711)40:5<2290::aid-cncr2820400541>3.0.co;2-t.
10
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.
Br J Cancer. 1976 Dec;34(6):585-612. doi: 10.1038/bjc.1976.220.
Zotero 插件